Lucid Diagnostics Inc. — Form D
Lucid Diagnostics Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-22. The offering totals $20.0M, of which $13.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-22
- Form: D
- Accession: 0001094891-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $13.6M
- Remaining: $6.4M
- Minimum investment: $250K
- Investors: 4
- Date of first sale: 2023-03-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-476613
Issuer
- Name: Lucid Diagnostics Inc.
- CIK: 0001799011
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 360 MADISON AVENUE, NEW YORK, NY, 10017
- Phone: 917-813-1828
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Lishan Aklog | Director | NEW YORK, NY |
| Lishan Aklog | Executive Officer | NEW YORK, NY |
| Debra J White | Director | NEW YORK, NY |
| DENNIS A MATHEIS | Director | NEW YORK, NY |
| STANLEY N LAPIDUS | Director | NEW YORK, NY |
| Stanley L Lapidus | Director | New York, NY |
| Michael A Gordon | Executive Officer | New York, NY |
| Jacque J Sokolov | Director | New York, NY |
| Dennis M McGrath | Executive Officer | New York, NY |
| Shaun M O'Neil | Executive Officer | New York, NY |
| James L Cox | Director | New York, NY |
| Ronald M Sparks | Director | New York, NY |
| Debra M White | Director | New York, NY |
Other filings by this issuer (3)
More